文献速递心脏核医学放射性药物与辐射防护

三维迭代重建在心脏SPECT中不止于降低剂量

3D iterative reconstruction can do so much more than reduce dose.
PubMed 文献 · J Nucl Cardiol · 2019-08-02

本文评述心脏SPECT软硬件进展,指出不应仅将新技术用于维持现状和降低辐射剂量,因低剂量方案已很低且降剂量获益证据很少。新重建技术可提升空间分辨率至可比甚至优于PET,并支持风险分层、分子示踪、高时间分辨率电生理管理及SPECT绝对血流定量。

要点

  • 心脏SPECT新技术应优先提升图像质量与患者诊疗,再优化剂量。
  • 低剂量成像方案下降剂量对患者的获益证据很少。
  • 新重建技术空间分辨率可比甚至优于PET。

核心结论

  • 心脏SPECT软硬件进展应首先用于改善图像和患者诊疗,然后优化剂量。
  • 仅将新技术用于维持现状和降低辐射剂量缺乏患者获益证据。

主要发现

  • 新重建技术可提供与PET可比、有时甚至更优的空间分辨率。
  • 心脏SPECT在风险分层、分子示踪和高时间分辨率电生理管理方面有巨大潜力。
  • 近期研究提示SPECT设备有潜力进行绝对血流定量。

临床怎么用

  • 临床应优先利用三维迭代重建提升图像质量与诊疗能力,而非仅降剂量。
  • 可探索SPECT在风险分层、分子示踪和电生理管理中的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent advances in software and hardware for cardiac SPECT have the potential to revolutionize nuclear cardiology. It is easy to use these technologies to maintain the status quo and lower radiation dose, despite the fact there is very little evidence that lowering patient dose in already low dose imaging protocols confers any benefit to patients. Cardiac SPECT has tremendous potential for risk stratification, molecular tracers, and high temporal resolution management of patients with electrophysiological disorders. In addition, these new reconstruction techniques can offer spatial resolution that is comparable and sometimes even superior to PET. Lastly, recent research has also held out the potential for performing absolute blood flow qualification using SPECT instrumentation. As these new technologies become available, the goal should be to make images better and improve patient care first, then optimize the dose.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Case JA. 3D iterative reconstruction can do so much more than reduce dose. J Nucl Cardiol. 2019. PMID: 31376003. doi:10.1007/s12350-019-01827-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。